Expense on other

[Table of Contents](#ifa3dff468a15495db7b57c65ada0de74_7)The results of discontinued operations during the three months ended March 31, 2022 and 2021, or through the disposal date of each asset or portfolio of assets if they have been sold during such periods, as applicable, are included in the consolidated results of operations for the three months ended March 31, 2022 and 2021. Summarized financial information for discontinued operations for the three months ended March 31, 2022 and 2021 are as follows (in thousands):

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Three Months EndedMarch 31, |  |  |
|  | 2022 |  | 2021 |  |  |  |  |
| Revenues: |  |  |  |  |  |  |  |
| Rental and related revenues | $ | —  |  |  | $ | 5,228  |  |  |  |  |  |
| Resident fees and services | 2,655  |  |  | 72,998  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |
| Total revenues | 2,655  |  |  | 78,226  |  |  |  |  |  |
| Costs and expenses: |  |  |  |  |  |  |  |
| Interest expense | —  |  |  | 2,676  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |
| Operating | 2,674  |  |  | 71,519  |  |  |  |  |  |
| Transaction costs | —  |  |  | 76  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |
| Total costs and expenses | 2,674  |  |  | 74,271  |  |  |  |  |  |
| Other income (expense): |  |  |  |  |  |  |  |
| Gain (loss) on sales of real estate, net | (71) |  |  | 259,662  |  |  |  |  |  |
| Other income (expense), net | 3  |  |  | 5,885  |  |  |  |  |  |
| Total other income (expense), net | (68) |  |  | 265,547  |  |  |  |  |  |
| Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | (87) |  |  | 269,502  |  |  |  |  |  |
| Income tax benefit (expense) | 340  |  |  | 821  |  |  |  |  |  |
| Equity income (loss) from unconsolidated joint ventures | 64  |  |  | (315) |  |  |  |  |  |
|  |  |  |  |  |  |  |  |
| Income (loss) from discontinued operations | $ | 317  |  |  | $ | 270,008  |  |  |  |  |  |

Impairments of Real EstateDuring the three months ended March 31, 2022 and 2021, the Company did not recognize any impairment charges.Other LossesDuring the three months ended March 31, 2022, the Company recognized $14 million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with a planned MOB demolition. NOTE 5.  Leases 

|  |  |  |
| --- | --- | --- |
|  |  |  |
|  |

Lease IncomeThe following table summarizes the Company’s lease income, excluding discontinued operations (in thousands):

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Three Months EndedMarch 31, |  |  |
|  | 2022 |  | 2021 |  |  |  |  |
|  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |
| Fixed income from operating leases | $ | 287,292  |  |  | $ | 262,937  |  |  |  |  |  |
| Variable income from operating leases | 82,858  |  |  | 65,035  |  |  |  |  |  |
| Interest income from direct financing leases | 1,168  |  |  | 2,163  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |

Direct Financing Leases2022 Direct Financing Lease SaleDuring the first quarter of 2022, the Company sold its remaining hospital classified as a direct financing lease (“DFL”) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. 13
